Stifel Financial Corp Sells 19,613 Shares of HCA Healthcare Inc (HCA)

Stifel Financial Corp lowered its stake in HCA Healthcare Inc (NYSE:HCA) by 43.9% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 25,104 shares of the company’s stock after selling 19,613 shares during the quarter. Stifel Financial Corp’s holdings in HCA Healthcare were worth $1,998,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in HCA. Northwestern Mutual Wealth Management Co. grew its stake in HCA Healthcare by 14.0% in the second quarter. Northwestern Mutual Wealth Management Co. now owns 1,163 shares of the company’s stock worth $101,000 after purchasing an additional 143 shares during the period. Bronfman E.L. Rothschild L.P. grew its stake in HCA Healthcare by 35.1% in the second quarter. Bronfman E.L. Rothschild L.P. now owns 1,232 shares of the company’s stock worth $107,000 after purchasing an additional 320 shares during the period. Atlantic Trust LLC purchased a new stake in HCA Healthcare in the second quarter worth $118,000. Acrospire Investment Management LLC grew its stake in HCA Healthcare by 14.3% in the second quarter. Acrospire Investment Management LLC now owns 1,600 shares of the company’s stock worth $140,000 after purchasing an additional 200 shares during the period. Finally, BB&T Investment Services Inc. purchased a new stake in HCA Healthcare in the second quarter worth $141,000. Hedge funds and other institutional investors own 75.25% of the company’s stock.

HCA Healthcare Inc (HCA) opened at $89.09 on Friday. HCA Healthcare Inc has a 1-year low of $71.18 and a 1-year high of $91.03. The company has a debt-to-equity ratio of -6.46, a current ratio of 1.68 and a quick ratio of 1.41. The firm has a market capitalization of $31,099.97, a PE ratio of 12.67, a price-to-earnings-growth ratio of 1.29 and a beta of 0.56.

HCA Healthcare (NYSE:HCA) last posted its earnings results on Tuesday, October 31st. The company reported $1.21 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.21. HCA Healthcare had a negative return on equity of 47.16% and a net margin of 6.13%. The company had revenue of $10.70 billion for the quarter, compared to the consensus estimate of $10.70 billion. During the same quarter in the prior year, the company earned $1.45 earnings per share. HCA Healthcare’s revenue was up 4.1% on a year-over-year basis. equities research analysts forecast that HCA Healthcare Inc will post 6.56 EPS for the current year.

In related news, SVP Victor L. Campbell sold 8,000 shares of the stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $78.00, for a total transaction of $624,000.00. Following the completion of the sale, the senior vice president now owns 127,275 shares in the company, valued at $9,927,450. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Michael S. Cuffe sold 2,150 shares of the stock in a transaction dated Tuesday, October 17th. The stock was sold at an average price of $78.00, for a total value of $167,700.00. Following the sale, the insider now owns 12,476 shares of the company’s stock, valued at approximately $973,128. The disclosure for this sale can be found here. In the last 90 days, insiders sold 22,700 shares of company stock valued at $1,773,872. Company insiders own 2.90% of the company’s stock.

Several equities research analysts recently weighed in on HCA shares. Cantor Fitzgerald reaffirmed a “buy” rating and issued a $95.00 price target on shares of HCA Healthcare in a research note on Wednesday, September 6th. SunTrust Banks set a $90.00 target price on HCA Healthcare and gave the stock a “buy” rating in a research note on Sunday, October 15th. Jefferies Group reissued a “buy” rating and issued a $92.00 target price on shares of HCA Healthcare in a research note on Friday, October 13th. Mizuho reissued a “buy” rating and issued a $92.00 target price on shares of HCA Healthcare in a research note on Wednesday, October 4th. Finally, Piper Jaffray Companies reissued a “buy” rating and issued a $92.00 target price on shares of HCA Healthcare in a research note on Wednesday, October 4th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and nineteen have issued a buy rating to the company. HCA Healthcare has a consensus rating of “Buy” and a consensus price target of $90.95.

TRADEMARK VIOLATION NOTICE: “Stifel Financial Corp Sells 19,613 Shares of HCA Healthcare Inc (HCA)” was first reported by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another website, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark law. The legal version of this report can be accessed at https://www.com-unik.info/2017/12/23/stifel-financial-corp-sells-19613-shares-of-hca-healthcare-inc-hca.html.

HCA Healthcare Profile

HCA Healthcare, Inc, formerly HCA Holdings, Inc, is a holding company. The Company, through its subsidiaries, owns and operates hospitals and related healthcare entities. As of December 31, 2016, the Company operated in two geographically organized groups, including the National and American Groups. As of December 31, 2016, the National Group included 84 hospitals, which were located in Alaska, California, Florida, southern Georgia, Idaho, Indiana, northern Kentucky, Nevada, New Hampshire, South Carolina, Utah and Virginia.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare Inc (NYSE:HCA).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

What are top analysts saying about HCA Healthcare? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for HCA Healthcare and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit